Partner | Cassels Brock & Blackwell LLP
Jonathan Sherman is a partner in our Business Law Group and Securities Group. Jonathan is also co-chair of the firm's Cannabis Group, one of only two Canadian law firms recognized as a Band 1 firm in cannabis by Chambers Canada.
Jonathan is routinely retained to act on behalf of a wide variety of cannabis industry participants, including: licensed and pre-licensed cultivators, processors and retailers in Canada, the United States and other international jurisdictions; pharmaceutical, beverage and consumer goods companies seeking opportunities to participate in the emerging global cannabis sector; and other ancillary businesses providing goods and services to the cannabis industry. As the cannabis sector continues to evolve, Jonathan is at the forefront of many of the largest industry transactions, providing strategic and legal advice to a range of leading industry players on complex and innovative transactions. His corporate clients range in size and stage from start-ups to multi-billion dollar businesses. Jonathan was recognized as a leading practitioner in the cannabis sector by Chambers Canada.
Jonathan’s practice has an emphasis on mergers and acquisitions and corporate finance transactions. His M&A practice involves various public and private acquisitions, business combinations, joint ventures, go-public transactions and strategic collaborations. Jonathan’s corporate finance experience includes public offerings, venture capital, private equity offerings, as well as debt financing transactions. He also regularly advises public, private, domestic and international clients on a broad range of complex corporate, commercial and securities matters, including supply arrangements, partnership agreements, licensing and royalty transactions and various other corporate governance matters.
Whether strategically guiding clients through M&A, or helping emerging start-ups secure investments, Jonathan has been a trusted advisor in many of the largest transactions completed to-date in the nascent cannabis industry, including advising Canopy Growth on: their listing as the first ever cannabis company on the New York Stock Exchange; over $1 billion of M&A transactions; a $600 million financing, the largest convertible debt financing to-date completed by a company listed on a Canadian stock exchange; the joint venture, licensing and development of the largest cannabis production facility in the world; and various supply and processing arrangements involving, among others, MediPharm Labs, 48North, Radicle Cannabis, James E. Wagner Cultivation, Neptune Technologies & Bioressources and Centric Health.
Jonathan has advised Canopy Rivers on: its listing on the TSX Venture Exchange and concurrent $104 million offering, the first go-public transaction completed by a company in the cannabis industry to be led by a Schedule 1 bank; and various venture capital transactions, including, among others, Canopy Rivers’ investments in TerrAscend, Radicle Cannabis, James E. Wagner Cultivation, LiveWell, Civilized Worldwide, Canapar, PharmHouse and Solo Growth.
Jonathan has also been involved in various other domestic cross-border transactions for participants in the cannabis industry, including: various private equity investments for emerging companies; reverse takeover transactions; joint ventures; and acquisitions and investments in companies both in Canada and abroad, including the United States, Italy, Denmark, Poland, Greece, Czech Republic, Colombia, Jamaica, Brazil, Chile, Australia and Lesotho.
Outside of the cannabis industry, Jonathan has advised on transactions in a variety of other industries, including natural resources, real estate, gaming, and other emerging industries such as blockchain and cryptocurrency.
Jonathan is a regular contributor to the Canadian Cannabis and Life Sciences blog. He is also regularly called upon as a thought leader in the cannabis industry speaking at industry events and in publications for The New York Times, The Globe & Mail, Reuters, The Financial Post and MJBizDaily.